Invention Grant
- Patent Title: Highly absorbable oral tyrosine formulation
-
Application No.: US16646787Application Date: 2018-09-21
-
Publication No.: US11278586B2Publication Date: 2022-03-22
- Inventor: Kotaro Tamura , Masazumi Iwashita , Yoshihiko Minegishi
- Applicant: Kao Corporation
- Applicant Address: JP Tokyo
- Assignee: Kao Corporation
- Current Assignee: Kao Corporation
- Current Assignee Address: JP Tokyo
- Agency: Sterne, Kessler, Goldstern & Fox P.L.L.C.
- Priority: JPJP2017-183667 20170925
- International Application: PCT/JP2018/035086 WO 20180921
- International Announcement: WO2019/059356 WO 20190628
- Main IPC: A61K38/05
- IPC: A61K38/05 ; A61K9/00 ; A61P25/00 ; A61P43/00 ; C07K5/06 ; A23L33/18
Abstract:
Provided is a tyrosine formulation excellent in bioabsorbability of tyrosine when ingested orally. An oral formulation with improved bioabsorbability of tyrosine, including glycyltyrosine or a salt thereof or a solvate thereof.
Public/Granted literature
- US20200261533A1 Highly Absorbable Oral Tyrosine Formulation Public/Granted day:2020-08-20
Information query
IPC分类:
